Time Course of Nigrostriatal Degeneration in Parkinson's Disease. A Detailed Study of Influential Factors in Human Brain Amine Analysis

Overview

Journal J Neural Transm

Specialties Neurology
Physiology

Date 1976 Jan 1

PMID 956814

Citations 136

Authors

P Riederer

S Wuketich

Affiliations

Soon will be listed here.

Abstract

It could be shown that the post mortem analysis of biogenic amines, precursors and metabolites in the human brain are influenced by various parameters. 1. The patient's medical history; long term observations of the course of the disease; age; sex. 2. Terminal illness; duration of terminal illness. 3. Previous treatment with drugs; last drugs. 4. Time interval between last drug treatment and death; time of day and date of last drug consumption. 5. Rapidity of death; time of death; duration of coma. 6. Changes occurring in tissues before death; patients' constitution during terminal illness. 7. Changes in concentration of the biogenic amines, precursors, and metabolites depending on the patient's age. 8. Time between death and necropsy. 9 Dissection of specimen. 10. Period of storage; temperature of storage. 11. Chronbiological rhythm of substances. 12. Methods of assayL 13. Homogeneity of all mentioned parameters in the control group and patient's group. For the first time it could be demonstrated that the time course of nigrostriatal degeneration, independent of the age of the parkinsonian at the beginning of the illness, is linear for the last stage and the denervation progressively increases as the duration of illness progresses.

Citing Articles

Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model.

Bianchetti M, Ferreira A, Britto L Front Neuroanat. 2024; 18:1511951.

PMID: 39736920 PMC: 11684390. DOI: 10.3389/fnana.2024.1511951.

Houston, We Have AI Problem! Quality Issues with Neuroimaging-Based Artificial Intelligence in Parkinson's Disease: A Systematic Review.

Dzialas V, Doering E, Eich H, Strafella A, Vaillancourt D, Simonyan K Mov Disord. 2024; 39(12):2130-2143.

PMID: 39235364 PMC: 11657025. DOI: 10.1002/mds.30002.

Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.

Collins H, Greenfield S Int J Mol Sci. 2024; 25(11).

PMID: 38892408 PMC: 11172947. DOI: 10.3390/ijms25116222.

Structural underpinnings and long-term effects of resilience in Parkinson's disease.

Dzialas V, Hoenig M, Prange S, Bischof G, Drzezga A, van Eimeren T NPJ Parkinsons Dis. 2024; 10(1):94.

PMID: 38697984 PMC: 11066097. DOI: 10.1038/s41531-024-00699-x.

Intranasal Administration of GRP78 Protein (HSPA5) Confers Neuroprotection in a Lactacystin-Induced Rat Model of Parkinson's Disease.

Pazi M, Belan D, Komarova E, Ekimova I Int J Mol Sci. 2024; 25(7).

PMID: 38612761 PMC: 11011682. DOI: 10.3390/ijms25073951.

References

QUAY W . Differential extractions for the spectrophotofluorometric measurement of diverse 5-hydroxy- and 5-methoxyindoles. Anal Biochem. 1963; 5:51-9. DOI: 10.1016/0003-2697(63)90057-5. View

Dowson J . The significance of brain-amine concentrations. Lancet. 1969; 2(7620):596-7. DOI: 10.1016/s0140-6736(69)90298-0. View

Coyle J, Snyder S . Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science. 1969; 166(3907):899-901. DOI: 10.1126/science.166.3907.899. View

Black I, Geen S . Postmortem changes in brain catecholamine enzymes. Arch Neurol. 1975; 32(1):47-9. DOI: 10.1001/archneur.1975.00490430069012. View

Riederer P, Birkmayer W, Neumayer E, AMBROZI L, Linauer W . The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome. J Neural Transm. 1974; 35(1):23-45. DOI: 10.1007/BF01245333. View

Post M, Sun A . The effect of chronic ethanol administration on the levels of catecholamines in different regions of the rat brain. Res Commun Chem Pathol Pharmacol. 1973; 6(3):887-94. View

EVERETT G, Borcherding J . L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice. Science. 1970; 168(3933):849-50. DOI: 10.1126/science.168.3933.849. View

Robinson D, Davis J, Nies A, RAVARIS C, Sylwester D . Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Arch Gen Psychiatry. 1971; 24(6):536-9. DOI: 10.1001/archpsyc.1971.01750120052009. View

Perry T, Berry K, Hansen S, Diamond S, Mok C . Regional distribution of amino acids in human brain obtained at autopsy. J Neurochem. 1971; 18(3):513-9. DOI: 10.1111/j.1471-4159.1971.tb11979.x. View

10.

Birkmayer W, Riederer P . Biochemical post-mortem findings in depressed patients. J Neural Transm. 1975; 37(2):95-109. DOI: 10.1007/BF01663627. View

11.

Ng K, Chase T, Colburn R, Kopin I . L-Dopa-induced release of cerebral monoamines. Science. 1970; 170(3953):76-7. DOI: 10.1126/science.170.3953.76. View

12.

Butcher L, Engel J . Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition. Brain Res. 1969; 15(1):233-42. DOI: 10.1016/0006-8993(69)90322-9. View

13.

Robinson D . Changes in monoamine oxidase and monoamines with human development and aging. Fed Proc. 1975; 34(1):103-7. View

14.

McGeer E, McGeer P, WADA J . Distribution of tyrosine hydroxylase in human and animal brain. J Neurochem. 1971; 18(9):1647-58. DOI: 10.1111/j.1471-4159.1971.tb03738.x. View

15.

Lajtha A, Toth J . Postmortem changes in the cerebral free amino acid pool. Brain Res. 1974; 76(3):546-51. DOI: 10.1016/0006-8993(74)90833-6. View

16.

Ashcroft G, SHARMAN D . Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Br J Pharmacol Chemother. 1962; 19:153-60. PMC: 1482248. DOI: 10.1111/j.1476-5381.1962.tb01436.x. View

17.

Joyce D . Changes in the 5-hydroxytryptamine content of rat, rabbit and human brain after death. Br J Pharmacol Chemother. 1962; 18:370-80. PMC: 1482122. DOI: 10.1111/j.1476-5381.1962.tb01417.x. View

18.

Tagliamonte A, Gessa R, Biggio G, Vargiu L, Gessa G . Daily changes of free serum tryptophan in humans. Life Sci. 1974; 14(2):349-54. DOI: 10.1016/0024-3205(74)90065-4. View

19.

BOGDANSKI D, Weissbach H, UDENFRIEND S . The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J Neurochem. 1957; 1(3):272-8. DOI: 10.1111/j.1471-4159.1957.tb12082.x. View

20.

Okada T, Fujita T, Ota T, Kato T, Ikuta K . A 24-hour rhythm in human serum dopamine-beta-hydroxylase activity. Experientia. 1974; 30(6):605-7. DOI: 10.1007/BF01921498. View